Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Cybin Inc
(NY:
CYBN
)
10.38
+0.13 (+1.27%)
Official Closing Price
Updated: 5:00 PM EST, Nov 29, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cybin Inc
< Previous
1
2
...
26
27
28
29
30
31
32
33
34
...
38
39
Next >
Cybin Announces Successful Completion of In Vivo Preclinical Studies for its Deuterated Psilocybin Analog CYB003 Supporting Advancement into Phase 1/2a Clinical Trial
March 29, 2022
From
Cybin Inc.
Via
Business Wire
Mindset Pharma, Small Pharma Among Top Psychedelic Movers Of Today
March 28, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 8.24% at $0.18
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 25, 2022
March 25, 2022
GAINERS: Allied (OTC:
Via
Benzinga
Cybin Subsidiary Achieves Milestone
March 25, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
Cybin Planning Pilot Study Of CYB004
March 22, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
Cybin (NEO: CYBN) (NYSE American: CYBN) Subsidiary Achieves Milestone
March 25, 2022
Via
Investor Brand Network
PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Subsidiary Achieves Milestone Outlined in Contribution Agreement
March 25, 2022
Via
Investor Brand Network
Cybin Announces Additional Adelia Milestone Achievement
March 25, 2022
From
Cybin Inc.
Via
Business Wire
Allied, Field Trip Health Among Top Psychedelic Movers Of Today
March 24, 2022
GAINERS: Allied (OTC:
Via
Benzinga
BioMedNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Commences Participant Recruitment in Feasibility Study Using Kernel Flow Technology
March 24, 2022
Via
Investor Brand Network
Five Companies Developing Second Generation Psychedelics For Mental Health
March 24, 2022
Along with the psychedelic renaissance came a new type of drug: second generation psychedelics. Developed from classic psychedelics ...
Via
Benzinga
Cybin-Sponsored Feasibility Study Using Kernel Flow Technology Currently Recruiting Participants
March 24, 2022
From
Cybin Inc.
Via
Business Wire
Psychedelic Stock Gainers And Losers From March 23, 2022
March 23, 2022
GAINERS: Compass Pathways (NASDAQ:
Via
Benzinga
Mindset Pharma, Compass Pathways Among Top Psychedelic Movers Of Today
March 22, 2022
GAINERS: Mind Medicine (NASDAQ:
Via
Benzinga
Cybin (NYSE American: CYBN) (NEO: CYBN) Planning Pilot Study of CYB004
March 22, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Field Trip Health, Mindset Pharma Among Top Psychedelic Movers Of Today
March 21, 2022
GAINERS: Field Trip Health (NASDAQ:
Via
Benzinga
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Planning Pilot Study of CYB004, Pursuing Multiple Opportunities to Secure, Support Patent Position for R&D
March 21, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Psychedelic Compounds-Based Drug Stocks Index Bounces Back
March 20, 2022
Updating the stock performances of the 13 constituents in our Pure-Play Marijuana and Psychedelic Compounds-Based Drug Stocks Index: up last week but still down 32% YTD.
Via
Talk Markets
Field Trip Health, Allied Among Top Psychedelic Movers Of Today
March 18, 2022
GAINERS: Field Trip Health (NASDAQ:
Via
Benzinga
Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) on Leading Edge of Development of Psychedelics as Public Support Grows
March 17, 2022
Via
Investor Brand Network
Psychedelic Stock Gainers And Losers From March 16, 2022
March 16, 2022
GAINERS: Mindset Pharma (OTC:
Via
Benzinga
PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Announces Participation in Upcoming Maxim Group Virtual Growth Conference
March 16, 2022
Via
Investor Brand Network
Cybin to Participate in the 2022 Maxim Group Virtual Growth Conference on March 28-30, 2022
March 16, 2022
From
Cybin Inc.
Via
Business Wire
Mind Medicine, Small Pharma Among Top Psychedelic Movers Of Today
March 15, 2022
GAINERS: Mind Medicine (NASDAQ:
Via
Benzinga
Wellbeing Digital, Small Pharma Among Top Psychedelic Movers Of Today
March 14, 2022
GAINERS: Wellbeing Digital (OTC:
Via
Benzinga
Seelos Therapeutics, Mind Medicine Among Top Psychedelic Movers Of Today
March 11, 2022
GAINERS: Allied (OTC:
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 10, 2022
March 10, 2022
GAINERS: Revive Therapeutics (OTC:
Via
Benzinga
Cybin Eyes Potential Of First-Of-Its-Kind Study
March 10, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Cybin (NYSE American: CYBN) (NEO: CYBN...
Via
Benzinga
Cybin (NYSE American: CYBN) (NEO: CYBN) Eyes Potential of First-of-Its-Kind Study
March 10, 2022
Via
Investor Brand Network
Psychedelic Stock Gainers And Losers From March 9, 2022
March 09, 2022
GAINERS: ATAI Life Sciences (NASDAQ:
Via
Benzinga
< Previous
1
2
...
26
27
28
29
30
31
32
33
34
...
38
39
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.